The global blood collection devices market generated revenue of approximately US$ 8.7 billion and is expected to experience consistent expansion through 2030, reaching an estimated value of over US$ 14 billion. This steady growth reflects a compound annual growth rate of around 6 % during the forecast period. Market momentum is being fueled by the rising volume of laboratory tests, improvements in diagnostic accuracy, and continuous innovation in device design. Leading manufacturers including Becton Dickinson, Terumo, Cardinal Health, and Thermo Fisher Scientific are investing heavily in product development to address evolving clinical and regulatory standards.
A major contributor to market growth is the increasing prevalence of chronic and infectious diseases worldwide. Conditions such as diabetes, cardiovascular disorders, autoimmune diseases, and renal impairment require frequent blood monitoring to guide treatment decisions. Additionally, the expanding global cancer burden has significantly increased demand for blood based diagnostics. Liquid biopsy techniques, which rely on blood samples to detect circulating tumor DNA and biomarkers, are becoming an integral part of oncology care. These advancements are driving sustained demand for high quality blood collection tubes, lancets, and safety engineered devices.
Request to sample Report-https://www.theinsightpartners.com/sample/TIPHE100001279
Market Driver
The expansion of point of care and decentralized diagnostic testing is another important driver shaping the blood collection devices market. Healthcare delivery is increasingly moving beyond traditional hospital settings into outpatient clinics, home healthcare, and emergency environments. In these settings, compact and user friendly blood collection devices are essential. Capillary blood sampling solutions, including fingerstick and heelstick devices, are gaining traction due to their ease of use, reduced patient discomfort, and suitability for rapid testing.
At the same time, patient safety and infection control have become top priorities for healthcare providers. The risk of needlestick injuries and bloodborne infections has accelerated adoption of safety enhanced blood collection systems, including retractable needles and closed system vacuum tubes. Regulatory bodies across developed and developing regions are enforcing stricter safety guidelines, further encouraging healthcare institutions to replace conventional devices with advanced alternatives.
Technological Progress
Innovation continues to reshape the blood collection landscape, particularly for populations with challenging venous access such as pediatric, geriatric, and critically ill patients. New generation devices integrate micro sampling technologies that require smaller blood volumes while maintaining diagnostic accuracy. Emerging solutions such as automated blood collection platforms and ultrasound assisted venipuncture systems aim to minimize human error, enhance workflow efficiency, and improve patient experience.
Market Segmentation
By product category, blood collection tubes remain the dominant segment, supported by their extensive use in clinical chemistry, hematology, immunology, and molecular diagnostics. Based on method, manual blood collection continues to account for a significant share of the market, although automated systems are gradually gaining adoption in high volume laboratories. Hospitals, diagnostic laboratories, and blood banks represent the primary end users, driven by rising patient admissions and preventive screening programs.
From a regional standpoint, North America leads the global market due to advanced healthcare infrastructure, high diagnostic awareness, and strong presence of key manufacturers. Europe follows closely, supported by favorable reimbursement policies and strict safety regulations. Meanwhile, Asia Pacific is expected to witness the fastest growth, driven by expanding healthcare access, increasing disease burden, and growing investments in laboratory infrastructure.
Key Companies Operating in the Market
• Becton Dickinson and Company
• Terumo Corporation
• Cardinal Health Inc
• SARSTEDT AG & Co KG
• Nipro Corporation
• Sekisui Chemical Co Ltd
• Thermo Fisher Scientific Inc
• Greiner Bio-One International GmbH
• FL Medical SRL
• IntervacTechnology OU
Future Outlook
Looking ahead, the blood collection devices market is poised for sustained expansion as healthcare systems place greater emphasis on early diagnosis, patient comfort, and operational efficiency. Advances in automation, digital integration, and minimally invasive sampling methods are expected to set new standards in blood collection practices. Furthermore, increasing healthcare investments in emerging economies and growing awareness of preventive testing will open new growth avenues. As diagnostic medicine continues to evolve, blood collection devices will remain indispensable to delivering accurate, timely, and patient focused care worldwide.
Related Report
